Company: Verastem Oncology
Job title: Associate Director
Silvia Coma is an Associate Director leading the Preclinical Work at Verastem Oncology. She earned her Pharm.D. degree and her Ph.D. degree in Molecular Biology from University of Barcelona in Catalonia. She completed her postdoctoral training in the field of tumor angiogenesis with Dr. Michael Klagsbrun at Boston Children’s Hospital, Boston. She has over 10 years of experience in molecular pathways in cancer, tumor models and drug discovery. She joined Verastem in 2019 and has worked across a wide variety of projects within Verastem oncology portfolio including PI3K-d,g inhibitors, FAK inhibitors and the novel RAF/MEK inhibitor CH5126766.